5R01AG057658-05 |
2022 |
$684076 |
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
5R01AG057658-04 |
2021 |
$684515 |
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
5R01AG057658-03 |
2020 |
$690558 |
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
3R01AG057658-03S1 |
2020 |
$54500 |
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
3R01AG057658-03S2 |
2020 |
$193430 |
Treating Alzheimer's disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
7R01AG057658-02 |
2019 |
$746208 |
Treating Alzheimers disease by reducing brain insulin resistance with incretin receptor agonists |
LOMA LINDA UNIVERSITY |
1R01AG057658-01 |
2018 |
$682885 |
Treating Alzheimers disease by reducing brain insulin resistance with incretin receptor agonists |
UNIVERSITY OF CALIFORNIA LOS ANGELES |